drugset / Trial / NCT07600385
A Study to Evaluate the Efficacy and Safety of UI022/UI023
RandomizedParallel-groupDouble-blindTreatment
Summary
Efficacy and Safety of Combined Cilostazol and Rosuvastatin Therapy Versus Rosuvastatin Alone in Patients with Chronic Lower Extremity Peripheral Artery Disease: A Multicenter, Double-Blind, Randomized Controlled Trial
Timeline
- Start
- 2019-03-12
- Primary completion
- 2022-05-03
- Completion
- 2022-05-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cilostazol | Small molecule | — | — |
| Comparator | Rosuvastatin | Small molecule | — | — |
| Subject | UI022 | Unknown | 1 unknown | — |
| Subject | UI023 | Unknown | 1 unknown | — |
| Comparator | UIC201604 | Unknown | 1 unknown | — |
| Comparator | UIC201801 | Unknown | 1 unknown | — |